Quantitative Lung Nodule Assessment of a Commercial AI-Based Software Package Using the FDA Phantom CT Dataset

Written By Stephanie Avila

Xiaotong Ouyang | Department of Public Health, Erasmus MC / iDNA - Institute for Diagnostic Accuracy, Netherlands

Stephanie Avila
Previous

AI Performance for Lung Nodule Growth in UK Lung Cancer Screening: Expert Consensus and Histology Validation
Next

Benchmarking CE-Certified AI Software Package on the Detection of the Reference Nodule in Lung Cancer Screening